Efficacy and safety of ibrutinib monotherapy in the treatment of relapsed/refractory mantle cell lymphoma

LEI Yaxin, QIAN Siyu, HOU Huting, GE Jingjing, WEN Qing, ZHANG Yue, KONG Xiaoshuang, WANG Wenhua, CHEN Qingjiang, ZHANG Mingzhi, ZHANG Xudong

PDF(1060 KB)
Tumor website：www.tumorsci.org E-mail Alert
PDF(1060 KB)
Tumor ›› 2021, Vol. 41 ›› Issue (11) : 758-767. DOI: 10.3781/j.issn.1000-7431.2021.2110-0802
Original Research

Efficacy and safety of ibrutinib monotherapy in the treatment of relapsed/refractory mantle cell lymphoma

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 41(11): 758-767 https://doi.org/10.3781/j.issn.1000-7431.2021.2110-0802

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1060 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Tumor, All Rights Reserved.
E-mail: tumor@tumorsci.org
Powered by Beijing Magtech Co., Ltd.

/

〈 〉